311.73 USD
-0.59 (-0.19%)
311.73 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 83% to ONC. The Buy consensus is the weighted average rating of the current analysts ratings.
ONC was analyzed by 16 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ONC.
In the previous month the buy percentage consensus was at a similar level.
ONC was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-24 | Truist Securities | Initiate | Buy |
| 2025-11-18 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-10 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-07 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-20 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-08 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-09-18 | Barclays | Initiate | Overweight |
| 2025-08-07 | Guggenheim | Maintains | Buy -> Buy |
| 2025-08-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-07-16 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-06-27 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-06-27 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-06-27 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-08 | Guggenheim | Maintains | Buy -> Buy |
| 2025-05-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-28 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-04-24 | TD Securities | Reiterate | Buy -> Buy |
| 2025-04-21 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-16 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-04-10 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-04-07 | RBC Capital | Initiate | Outperform |
| 2025-02-28 | Citizens Capital Markets | Maintains | Market Outperform -> Market Outperform |
| 2025-02-28 | Macquarie | Maintains | Outperform -> Outperform |
BEONE MEDICINES LTD-ADR / ONC FAQ
What is the consensus rating for BEONE MEDICINES LTD-ADR (ONC) stock?
The consensus rating for BEONE MEDICINES LTD-ADR (ONC) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover BEONE MEDICINES LTD-ADR (ONC) stock?
The number of analysts covering BEONE MEDICINES LTD-ADR (ONC) is 16.